PRESS RELEASE: New advance in DNA testing

Latest Press Release

Haplomic Technologies a biotech company based in Melbourne have reported that they have achieved single chromosome sequencing. In a collaborative arrangement with Minifab who are owned by the German company Schott They have engineered a small cartridge which is able to trap a single cell and break it open to release the chromosome content. Single chromosomes have been selected and DNA sequenced. The unique information obtained allows multiple sequence variations in genes to be assigned accurately to a single chromosome which is termed genetic phasing. To do this previously required expensive and time consuming family studies. The clinical application of this work is in many areas but principally in bone marrow transplantation using unrelated donors. Genetic phasing has never been achieved previously in this field and represents a breakthrough in the study of genetics and human diseases

Media Contacts:

Name: Brian TaitCompany: Haplomic TechnologiesEmail: [email protected]Phone: +61419394352

Attachments:

October 26, 2022/by Reland Pigte

About Haplomic Technologies

The Company Haplomic Technologies Pty Ltd (HT) was established in 2004 by the late Dr Malcolm Symons and Mr Geoff Swanson for the specific objectives of developing intellectual property, for the DNA sequencing of single chromosomes to determine haplotypic phase. HT was granted over 20 international patents on the clinical applications of haplotyping from 2004 to 2012. The close professional working relationship between Dr Brian Tait and HT for many years generated volumes of laboratory data and technical substance on haplotyping which contributed significantly to the development of HT’s knowledge base and future commercial prospects. However, at that stage there were no reliable methods for routinely isolating single chromosomes from single cells for sequencing, while the scientific world was reporting widely that haplotyping represented one of the greatest opportunities for understanding the genetics of many complex diseases! In 2008, Geoff Swanson proposed the concept of using microfluidics to separate, isolate and collect single chromosomes from a single cell.

TERMS OF USE

By sending a press release and/or signing up for a subscription of our service Get The Word Out, you agree to the following terms of use, limitations, quality policy and fair use policy. Get The Word Out reserves the right to suspend or delete your account if any of the terms below are believed not to have been adhered to. Get The Word Out reserves the right to delete any content that does meet the following terms and policies.

1. Accuracy

By using Get The Word Out, you agree to only publish information that you know to be true and accurate. You are solely responsible for the facts and accuracy of all information submitted by you for distribution by Get The Word Out. Get The Word Out will make reasonable efforts to correct any error of fact brought to its attention.

2. Acceptable content

You agree to only submit content that might be classified as a “news announcement”. That is: it is a new event or statement related to the company or organisation that the release is being submitted under. You agree not to use Get The Word Out to distribute how-to articles, generally-information articles, whitepapers, or opinions. You must not submit content that infringes on copyright or the proprietary rights of a third party, or is unlawful or offensive. Releases must adhere to professional standards and may be deleted if they do not. You acknowledge that we reserve the right to edit your release's headline, subject and body text to ensure it is appropriate, relevant and suitable for the purpose.

3. Attribution

You agree to submit content only on behalf of the organisation that the release is being submitted under. Content that may be considered misleading in terms of who the material is being submitted by, or in terms of who the content is related to should not be posted and may be deleted or edited. When submitting a release you must be the owner of the email that is being used to send emails via Get The Word Out.

4. Categorisation

You agree to categorise content only under those categories that are relevant to the content. In general, we advise attempts to categorise content under more than five categories will lead to that content being reviewed and possibly removed. You acknowledge that we reserve the right to edit release's tags to ensure your release is sent only to relevant people.

5. Linking and fair-use

You agree not to add more than one link to a website in any press release. Over-linking solely for Search Engine Optimisation purposes is not allowed and is advised against due to penalties that may be associated with over-linking. And our gremlins will hunt down over-linking and delete such transgressions.

Inquiries concerning any Get The Word Out content including text, photos, video, audio and other content, or that may be related to the use of the Get The Word Out service should be addressed to The Director, Digitaliyf Pty Ltd of PO Box 3045, Newstead, 4006 Australia.